Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice.
Colaneri M, Genovese C, Lombardi A, Holmes D, Bandera A, Gori A. Colaneri M, et al. Eur J Clin Microbiol Infect Dis. 2024 May;43(5):1017-1023. doi: 10.1007/s10096-024-04798-8. Epub 2024 Mar 8. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38457097 Free PMC article.
An explainable model of host genetic interactions linked to COVID-19 severity.
Onoja A, Picchiotti N, Fallerini C, Baldassarri M, Fava F; GEN-COVID Multicenter Study; Colombo F, Chiaromonte F, Renieri A, Furini S, Raimondi F. Onoja A, et al. Commun Biol. 2022 Oct 26;5(1):1133. doi: 10.1038/s42003-022-04073-6. Commun Biol. 2022. PMID: 36289370 Free PMC article.
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R; WES/WGS Working Group Within the HGI; GenOMICC Consortium; GEN-COVID Multicenter Study; Mari F, Renieri A, Furini S. Fallerini C, et al. Hum Genet. 2022 Jan;141(1):147-173. doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. Hum Genet. 2022. PMID: 34889978 Free PMC article.
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?
Lombardi A, Colaneri M, Vijayagopal KA, Sambo M, Legnazzi P, Sacchi P, Zuccaro V, Maiocchi L, Maserati R, Gulminetti R, Pagnucco L, Novati S, Zanaboni D, Michelone G, Ludovisi S, Mondelli MU, Bruno R. Lombardi A, et al. Among authors: colaneri m. Dig Liver Dis. 2021 Apr;53(4):456-460. doi: 10.1016/j.dld.2020.07.013. Epub 2020 Jul 27. Dig Liver Dis. 2021. PMID: 32732070
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
Fabbiani M, Lombardi A, Colaneri M, Del Poggio P, Perini P, D'Ambrosio R, Degasperi E, Dibenedetto C, Giorgini A, Pasulo L, Maggiolo F, Castelli F, Brambilla P, Spinelli O, Re T, Lleo A, Rumi M, Uberti-Foppa C, Soria A, Aghemo A, Lampertico P, Baiguera C, Schiavini M, Fagiuoli S, Bruno R; NAVIGATORE-Lombardia Study Group. Fabbiani M, et al. Among authors: colaneri m. J Viral Hepat. 2021 Mar;28(3):558-568. doi: 10.1111/jvh.13454. Epub 2021 Jan 2. J Viral Hepat. 2021. PMID: 33306247
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey.
Lombardi A, Colaneri M, Sambo M, Di Matteo A, Sacchi P, Fabbiani M, Codecasa L, Aliberti S, Blasi F, Bandera A, Bruno R, Gori A. Lombardi A, et al. Among authors: colaneri m. Respir Med. 2021 Apr;179:106341. doi: 10.1016/j.rmed.2021.106341. Epub 2021 Feb 15. Respir Med. 2021. PMID: 33618080 Free article.
107 results